Optimizing effect of the combined administration of 8-OH-DPAT and galantamine on depression-anxiety behavior in old rats with dementia of Alzheimer's type

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 69, Issue 3, 2006, Pages 10-13

  Sapronov, N S ^a   Fedotova, Yu O ^a   Losev, N A ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 (2 PHTHALIMIDO)BUTYL)PIPERAZINE; 1-(2-METHOXYPHENYL)-4-(4-(2-PHTHALIMIDO)BUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CHOLINESTERASE INHIBITOR; GALANTAMINE; PIPERAZINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST;

AGING; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; ARTICLE; COMPARATIVE STUDY; DEPRESSION; DRUG ANTAGONISM; DRUG EFFECT; MALE; RAT; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AGING; ALZHEIMER DISEASE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; DEPRESSION; GALANTAMINE; MALE; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS;

EID: 33746822403     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Y. Abe, A. Aoyagi, T. Hara, et al., J. Pharmacol. Sci., 93, 95-105 (2003).
2. A. C. Dringenberg and P. Diavolitsis, Neuropharmacol., 42, 154-161 (2002)
3. E. Fifkova and J. Marsala, Stereotaxic atlases for the cat, rabbit and rat brains. Praha, St. zdravotnicke nakald (1960).
4. M. Luttgen, E. Elvander, N. Madjid, and S. O. Ogren, Neuropharmacol., 48, 830-852 (2005).
5. M. F. Mendez, R. J. Martin, K. A. Smyth, et al., J. Neuropsych. Clin. Neurosci., 2, 28-33 (1990).
6. The Neurobiology of Alzheimer's Disease., Ann. N. Y. Acad. Sci., 777 (1996).
7. M. Ohno and S. Watanabe, Brain Res, 736, 180-188 (1996).
8. J. P. Olie, J. Costa E Silva, and J. P. Macher, Neuroplasticity: a new approach to the pathophysiology of depression, Science Press, London UK (2004).
9. A. M. Palmer and S. T. DeKosky, J. Neural. Transm., 91, 135-159 (1993).
10. R. D. Porsolt, G. Anton, N. Blavet, et al, Eur. J. Pharmacol., 47, 379-391 (1978).
11. Jr. P. Riekkinen, Eur. J. Pharmacol, 262, 77-90 (1994).
12. R. J. Rodgers, B. J. Cao, A. Dalvi A., et al., Braz. J. Med. Biol. Res., 30, 289-304 (1997).
13. G. L. Wenk, D. J. Pierce, R. G. Struble, et al., Neurobiol. Aging, 10, 11-19 (1989).
14. W. J. Wilson and J. A. Cook, Acta Neurobiol. Exp., 154, 377-381 (1994).